drugset / Trial / NCT06669169

Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure

NCT06669169 ↗

Phase 2 Not yet recruiting 288 enrolled Tasly Pharmaceutical Group Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Evaluate the efficacy and safety of Jia Shen Tablets in patients with Chronic Heart Failure.

Timeline

Start
2025-01-31
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Jia Shen Tablet Unknown 0.94 g Oral
Subject Jia Shen Tablet Unknown 1.88 g Oral

Indications